Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-27

Clinical Trial Update: Maximal Use of Luliconazole Cream 1% in Pediatric Participants With Moderate to Severe Tinea Pedis or Tinea Cruris [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating maximal use of luliconazole 1% cream in children with moderate to severe tinea pedis or tinea cruris; study completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • luliconazole 1% cream (luliconazole)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Tinea Pedis, Tinea Cruris | Phase 4 | Status: COMPLETED | Results posted: 2019-11-27